Cannara Biotech Inc.
LOVE.V
Get informed when a big investor buys or sells
+ FollowMarket Cap$205.47M
Close$
Share Statistics
| Market cap | $205.47 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.14 |
| Beta | 0.34 |
| Outstanding Shares | 96,357,537 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 18.31 |
|---|---|
| PEG | 108.27 |
| Price to Sales | 1.89 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cannara Biotech Inc.
452 employees
CEO: Zohar Krivorot Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing bo...